Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 3 results.

- Journal article
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study.
D'hondt, Véronique[UCL] Humblet, Yves[UCL] Guillaume, T. Baatout, S. Chatelain, Christian[UCL] Berlière, M[UCL] Longueville, Jacques[UCL] Feyens, Anne Marie[UCL] De Greve, J. Van Oosterom, A. (1995) Blood — Vol. 85, no. 9, p. 2347-53 (1995)
- Speech
A multicenter Phase II trial of gefitinib 500 mg/day in 192 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy.
Vergote, Ignace[UCL] Humblet, Yves[UCL] Van Cutsem, Emmanuel[UCL] Van Belle, S. Kerger, Joseph Van Laethem, J. Canon, J. Forget, F. Amant, Frederic[UCL] Van Oosterom, A. (2005) —
- Speech
A multicenter phase II trial of gefitinib 500 mg/day in 193 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy: Interim data
Vergote, IB Humblet, Yves Van Cutsem, E. Van Belle, S. Kerger, Joseph Van Laethem, JL Canon, JL. Forget, F. Strobbe, E Van Oosterom, A. (2005) 41st Annual Meeting of the American-Society-of-Clinical-Oncology — Orlando (Fl)